Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 04 2025
0mins
Source: PRnewswire
Corporate Presentation Announcement: Armata Pharmaceuticals will have a corporate presentation at the H.C. Wainwright 27th Annual Global Investment Conference in New York from September 8-10, 2025, with their presentation scheduled for September 10 from 1:30-2:00 PM ET.
Focus on Bacteriophage Therapeutics: The company specializes in developing high-purity, pathogen-specific bacteriophage therapeutics aimed at treating antibiotic-resistant bacterial infections, with a pipeline that includes candidates for pathogens like Pseudomonas aeruginosa and Staphylococcus aureus.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
